These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 12519890)
1. Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma. Huang SC; Torres-Cruz J; Pack SD; Koch CA; Vortmeyer AO; Mannan P; Lubensky IA; Gagel RF; Zhuang Z J Clin Endocrinol Metab; 2003 Jan; 88(1):459-63. PubMed ID: 12519890 [TBL] [Abstract][Full Text] [Related]
2. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. Kameyama K; Okinaga H; Takami H Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413 [TBL] [Abstract][Full Text] [Related]
3. Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma. Koch CA; Huang SC; Moley JF; Azumi N; Chrousos GP; Gagel RF; Zhuang Z; Pacak K; Vortmeyer AO Oncogene; 2001 Nov; 20(53):7809-11. PubMed ID: 11753660 [TBL] [Abstract][Full Text] [Related]
4. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225 [TBL] [Abstract][Full Text] [Related]
5. Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition. Elisei R; Cosci B; Romei C; Agate L; Piampiani P; Miccoli P; Berti P; Basolo F; Ugolini C; Ciampi R; Nikiforov Y; Pinchera A J Clin Endocrinol Metab; 2004 Nov; 89(11):5823-7. PubMed ID: 15531548 [TBL] [Abstract][Full Text] [Related]
6. [The RET gene in multiple endocrine neoplasia type 2 (MEN 2)]. Ito T; Shirahama S; Ogura K; Yamamoto S; Takami H Nihon Rinsho; 2004 May; 62(5):883-8. PubMed ID: 15148813 [TBL] [Abstract][Full Text] [Related]
7. Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas. Huang SC; Koch CA; Vortmeyer AO; Pack SD; Lichtenauer UD; Mannan P; Lubensky IA; Chrousos GP; Gagel RF; Pacak K; Zhuang Z Cancer Res; 2000 Nov; 60(22):6223-6. PubMed ID: 11103773 [TBL] [Abstract][Full Text] [Related]
8. Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome. Poturnajova M; Altanerova V; Kostalova L; Breza J; Altaner C J Mol Med (Berl); 2005 Apr; 83(4):287-95. PubMed ID: 15592804 [TBL] [Abstract][Full Text] [Related]
13. [Medullary thyroid carcinoma and some of its particularities]. Sidibé el H Sante; 2007; 17(1):51-5. PubMed ID: 17897902 [TBL] [Abstract][Full Text] [Related]
14. [Medullary cancers of the thyroid: genetic aspects]. Orgiazzi J Ann Endocrinol (Paris); 2003 Oct; 64(4):345-9. PubMed ID: 14595251 [No Abstract] [Full Text] [Related]
15. Molecular pathogenesis of MEN2-associated tumors. Koch CA Fam Cancer; 2005; 4(1):3-7. PubMed ID: 15883703 [TBL] [Abstract][Full Text] [Related]
16. Kindred with prominent corneal nerves associated with a mutation in codon 804 of RET on chromosome 10q11. Ong DS; Lakhani V; Oates JA; O'Day DM Arch Ophthalmol; 2010 Feb; 128(2):247-9. PubMed ID: 20142552 [No Abstract] [Full Text] [Related]
17. Management of patients with hereditary medullary thyroid carcinoma. Fitze G Eur J Pediatr Surg; 2004 Dec; 14(6):375-83. PubMed ID: 15630638 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881 [TBL] [Abstract][Full Text] [Related]
19. Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma/multiple endocrine neoplasia type 2A patients. Lesueur F; Cebrian A; Cranston A; Leyland J; Faid TM; Clements MR; Robledo M; Whittaker J; Ponder BA J Clin Endocrinol Metab; 2005 Jun; 90(6):3454-7. PubMed ID: 15741265 [TBL] [Abstract][Full Text] [Related]
20. Interaction of RET proto-oncogene codon 609 germline mutations with RET haplotypes characterized by c.135G>A alleles modifying MEN 2A or HSCR phenotypes. Fitze G; Schreiber M; Hohenberger W; Hümmer HP; Roesner D; Schackert HK Am J Med Genet A; 2004 Sep; 129A(3):323-5. PubMed ID: 15326638 [No Abstract] [Full Text] [Related] [Next] [New Search]